BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1933904)

  • 21. [Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors].
    Wiman KG
    Lakartidningen; 1992 Sep; 89(39):3169-74. PubMed ID: 1405928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis.
    Tamura G; Kihana T; Nomura K; Terada M; Sugimura T; Hirohashi S
    Cancer Res; 1991 Jun; 51(11):3056-8. PubMed ID: 2032245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
    Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
    Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
    Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of the p53 gene are not detectable in human testicular tumors.
    Fleischhacker M; Strohmeyer T; Imai Y; Slamon DJ; Koeffler HP
    Mod Pathol; 1994 May; 7(4):435-9. PubMed ID: 8066072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 protects against skin cancer induction by UV-B radiation.
    Jiang W; Ananthaswamy HN; Muller HK; Kripke ML
    Oncogene; 1999 Jul; 18(29):4247-53. PubMed ID: 10435637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.
    Ricevuto E; Ficorella C; Fusco C; Cannita K; Tessitore A; Toniato E; Gabriele A; Frati L; Marchetti P; Gulino A; Martinotti S
    Am J Pathol; 1996 Feb; 148(2):405-13. PubMed ID: 8579104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
    Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma.
    Adesina AM; Nalbantoglu J; Cavenee WK
    Cancer Res; 1994 Nov; 54(21):5649-51. PubMed ID: 7923211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome instability in secondary solid tumors developing after radiotherapy of bilateral retinoblastoma.
    Lefèvre SH; Vogt N; Dutrillaux AM; Chauveinc L; Stoppa-Lyonnet D; Doz F; Desjardins L; Dutrillaux B; Chevillard S; Malfoy B
    Oncogene; 2001 Dec; 20(56):8092-9. PubMed ID: 11781822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma.
    Kim JW; Cho YH; Kwon DJ; Kim TE; Park TC; Lee JM; Namkoong SE
    Gynecol Oncol; 1995 May; 57(2):199-204. PubMed ID: 7729734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
    Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
    Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infrequent p53 gene mutations in medulloblastomas.
    Saylors RL; Sidransky D; Friedman HS; Bigner SH; Bigner DD; Vogelstein B; Brodeur GM
    Cancer Res; 1991 Sep; 51(17):4721-3. PubMed ID: 1873817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanisms for inactivation of tumor suppressor genes].
    Ishizaki K
    Nihon Rinsho; 1995 Nov; 53(11):2660-5. PubMed ID: 8538022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.
    Corradini P; Inghirami G; Astolfi M; Ladetto M; Voena C; Ballerini P; Gu W; Nilsson K; Knowles DM; Boccadoro M
    Leukemia; 1994 May; 8(5):758-67. PubMed ID: 8182933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The p53 tumor suppressor gene of the marsupial Monodelphis domestica: cloning of exons 4-11 and mutations in exons 5-8 in ultraviolet radiation-induced corneal sarcomas.
    Kusewitt DF; Sherburn TE; Miska KB; Tafoya GB; Gale JM; Miller RD
    Carcinogenesis; 1999 Jun; 20(6):963-8. PubMed ID: 10357774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of a metastasizing testicular mixed gonadal stromal tumor with osteosarcoma components suggests that a malignant tumor with the histology of osteosarcoma may develop without primary involvement of RB1 and TP53.
    Reuvekamp PT; Stulp RP; Schraffordt Koops H; Oosterhuis JW; Scheffer H; Buys CH
    Cancer Res; 1992 Dec; 52(23):6705-7. PubMed ID: 1423318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.